Company News

Valeant Sells Obagi Medical

Author Image

By: Christine Esposito

Editor-in-Chief

Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acquisition Fund I, L.P. “The sale of Obagi marks additional progress in our efforts to streamline our operations and reduce debt,” Joseph C. Papa, chairman and CEO, Valeant. “As we continue to transform Valeant, we will remain focused on the core businesses that will drive high value for our ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters